| Synonyms: | |
| Status: | Approved (2010) |
| Entry Type: | Unknown |
| Molecule Category: | UNKNOWN |
| UNII: | E211KPY694 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Synaptosomal nerve-associated protein 25 (SNAP-25) inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Bruxism | 3 | D002012 | ClinicalTrials |
| Blepharospasm | 3 | D001764 | ClinicalTrials |
| Stroke | 3 | D020521 | ClinicalTrials |
| Urinary Bladder, Overactive | 3 | D053201 | ClinicalTrials |
| Torticollis | 3 | D014103 | ClinicalTrials |
| Muscle Spasticity | 3 | D009128 | ClinicalTrials |
| Dystonic Disorders | 3 | D020821 | ClinicalTrials |
| Parkinson Disease | 3 | D010300 | ClinicalTrials |
| Blepharospasm | 3 | D001764 | ClinicalTrials |
| Cerebral Palsy | 2 | D002547 | ClinicalTrials |
| Pain | 2 | D010146 | ClinicalTrials |
| Tremor | 2 | D014202 | ClinicalTrials |
| Essential Tremor | 2 | D020329 | ClinicalTrials |
| Snoring | 2 | D012913 | ClinicalTrials |
| Trigeminal Neuralgia | 2 | D014277 | ClinicalTrials |
| Rosacea | 2 | D012393 | ClinicalTrials |
| Diabetic Neuropathies | 2 | D003929 | ClinicalTrials |
| Sleep Apnea Syndromes | 2 | D012891 | ClinicalTrials |
| Borderline Personality Disorder | 2 | D001883 | ClinicalTrials |
| Alopecia | 2 | D000505 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2108035 |
| FDA SRS | E211KPY694 |
CONTENTS